The targeted therapeutic drug for non-small-cell lung cancer with epidermal growth factor receptor Exon 20 insertion mutations: sunvozertinib

doi:10.3969/j.issn.1672-3384.2025.01.007

Jing WANG, Zinan ZHAO, Pengfei JIN

Clinical Medication Journal ›› 2025, Vol. 23 ›› Issue (1) : 35-39.

PDF(503 KB)

Clinical Medication Journal ›› 2025, Vol. 23 ›› Issue (1) : 35-39. DOI: 10.3969/j.issn.1672-3384.2025.01.007

Comment of New Drug

The targeted therapeutic drug for non-small-cell lung cancer with epidermal growth factor receptor Exon 20 insertion mutations: sunvozertinib

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2025, 23(1): 35-39 https://doi.org/10.3969/j.issn.1672-3384.2025.01.007

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(503 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2024-09-15	2025-01-10
Issue Date
2025-02-27

Please choose a citation manager

Content to export